{"id":"W4411373157","doi":"10.1016/j.ejca.2025.115584","title":"Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial","year":2025,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; Ottawa Hospital; University Health Network","funders":"National Cancer Institute; Clovis Oncology","keywords":"Placebo; Medicine; Oncology; Internal medicine; Ovarian carcinoma; Ovarian cancer; Cancer; Pathology; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001597651,0.001029889,0.002563987,0.0002542255,0.0003209965,0.0008912453,0.0008407239,0.001153996,0.003617445],"category_scores_gemma":[0.001444592,0.0003111698,0.001999957,0.0003708996,0.0007569361,0.0009822232,0.000305124,0.003703595,0.000738978],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005818066,"about_ca_system_score_gemma":0.0007122784,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001007034,"about_ca_topic_score_gemma":0.002982545,"domain_scores_codex":[0.9995885,0.0002028632,0.00001987675,0.00006782246,0.00004037709,0.00008050169],"domain_scores_gemma":[0.9993833,0.0001934871,0.0001332771,0.00007252433,0.00003470982,0.0001827068],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9248914,0.00247017,0.001722276,0.001251683,0.003059781,0.00009230082,0.00008717848,0.0008070523,0.004564908,0.0002496816,0.003063171,0.05774032],"study_design_scores_gemma":[0.9347601,0.0503943,0.008281782,0.00008744353,0.001664625,0.0001630016,0.00004345603,0.0008590266,0.0008682805,0.0003977345,0.002450371,0.00003002663],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9712198,0.01981284,0.000992671,0.001137757,0.0005042686,0.0009049011,0.001789252,0.0003155081,0.003323036],"genre_scores_gemma":[0.9867432,0.004855046,0.001207276,0.001472089,0.0003453033,0.0007256533,0.002012429,0.00005679519,0.002582027],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003617445,"threshold_uncertainty_score":0.01210153,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04079906210408889,"score_gpt":0.3484937278941718,"score_spread":0.3076946657900829,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}